Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy

被引：0
|
作者：
R. H. Enting
P. Portegies
机构：
[1] Department of Neurology,
[2] Academic Medical Center H2-214,undefined
[3] Meibergdreef 9,undefined
[4] 1105 AZ,undefined
[5] Amsterdam,undefined
[6] The Netherlands e-mail: P.Portegies@amc.uva.nl Tel.: +31-20-5663842 Fax: +31-20-6971438,undefined
来源：
Journal of Neurology | 2000年 / 247卷
关键词：
Key words Progressive multifocal leukoencephalopathy; Anti-HIV agents; Cytarabine; HIV infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We assessed survival in AIDS-related progressive multifocal leukoencephalopathy (PML) and the effect of cytarabine and antiretroviral therapy in a retrospective analysis of a series of consecutive 35 patients with AIDS-related PML in an academic AIDS referral center over ¶15 years. Treatment regimens consisted of highly active antiretroviral treatment (HAART), intravenous cytarabine, or both. Median survival after diagnosis in the overall series was 88 days. Patients with low CD4 cell count tended to have shorter survival. Seven patients (20%) had prolonged survival (> 1 year). Cytarabine did not affect survival. Seven patients were treated with HAART, which did not significantly improve survival. We conclude that the prognosis of AIDS-related PML is still poor, with a median survival of ¶3 months.
引用
收藏
页码：134 / 138
页数：4
相关论文
共 50 条
  • [31] Successful use of cidofovir for progressive multifocal leukoencephalopathy (PML) occurring while on highly active antiretroviral therapy (HAART)
    Razonable, RR
    Aksamit, AJ
    Wright, AJ
    Wilson, JW
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1210 - 1210
  • [32] Impact of highly active antiretroviral therapy on survival from progressive multifocal leukoencephalopathy in human immunodeficiency virus infection
    Clifford, DB
    NEUROLOGY, 1998, 50 (04) : A249 - A249
  • [33] Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection
    Power, C
    Nath, A
    Aoki, FY
    DelBigio, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (09): : 661 - 662
  • [34] Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease
    Ribera, JM
    Navarro, JT
    Oriol, A
    López-Guillermo, A
    Sureda, A
    Abella, E
    Hernández-Rivas, JA
    Xicoy, B
    Grau, J
    Batlle, M
    Feliu, E
    AIDS, 2002, 16 (14) : 1973 - 1976
  • [35] The changing landscape of HIV-related lung disease in the era of highly active antiretroviral therapy
    O'Neil, KM
    CHEST, 2002, 122 (03) : 768 - 771
  • [36] Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy
    Thurnher, MM
    Post, MJD
    Rieger, A
    Kleibl-Popov, C
    Loewe, C
    Schindler, E
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2001, 22 (05) : 977 - 984
  • [37] Baseline neuroimaging features and long term disability in AIDS-related progressive multifocal leukoencephalopathy (PML) on highly active antiretroviral therapy (HAART)
    De Luca, Andrea
    Adriana, Ammassari
    Berencyuer, Juan
    Cinque, Paola
    Di Giambenedetto, Simona
    Cingolani, Antonella
    Larussa, Dora
    Pedale, Rosa
    Tartaglione, Tommaso
    Gerevini, Simonetta
    Post, M. Judith Donovan
    Bowen, Brian C.
    Ruiz, Armando
    Gasnault, Jacques
    Moretti, Francesca
    Finazzi, Maria Grazia
    Pezzotti, Patrizio
    Marra, Christina M.
    Antinori, Andrea
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 50 - 50
  • [38] Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy
    De Luca, A
    Ammassari, A
    Cingolani, A
    Giancola, ML
    Antinori, A
    AIDS, 1998, 12 (14) : 1937 - 1938
  • [39] HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy
    Campa, A
    Yang, ZF
    Lai, SH
    Xue, LH
    Phillips, JC
    Sales, S
    Page, JB
    Baum, MK
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (08) : 1179 - 1185
  • [40] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AND CYTARABINE - REMISSION WITH TREATMENT
    BAUER, WR
    TUREL, AP
    JOHNSON, KP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 226 (02): : 174 - 196
12345